OTC Markets
Prev Close 0.07
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.04 / 0.11
Exchange OTC Markets
Shares Outstanding 369.93B
Market Cap 28.85M
Div & Yield N.A. (N.A)

The AsepticSure® Hospital Disinfection System Introduced To South America

AsepticSure®, the only hospital disinfection system in the world that achieves 100% bactericidal kill, dramatically reducing new rates of hospital acquired infections in the rooms treated, will be distributed in South America by GYD S.A.

AsepticSure Moves Closer To US Launch As Medizone International's Board Of Directors Is Expanded To Add Significant Business Development And Strategy Strength

New Medizone Board Member David Esposito - Key Commercial Leader For Phadia Sale to Thermo Fisher Scientific for $3.5 Billion USD

Patent Protection Granted For The Elimination Of Anthrax

The ability to remediate buildings following a weaponized biological attack may have been achieved with AsepticSureA®

AsepticSure Hospital Disinfection Technology Receives US Patent Protection

In a world-first, a new green technology capable of decontaminating infected hospital and health care rooms to the standard of > 6 log (>99.9999%) has received US patent protection.

New Ozone-Based Disinfection Technology Eradicates MRSA From Infected Hospital Rooms - In Less Than 60 Minutes

AsepticSure®, a radical new infection control technology successfully achieves 100% microbial kill rates in MRSA-infected rooms at Ontario's QHC Belleville General Hospital - with exposure times of less than an hour.

AsepticSure Distribution Agreement Opens Door To Canadian Hospital Market

Hospital disinfection technology, AsepticSure, to be distributed nation-wide by Wood Wyant, Canada's largest distributor of sanitation products

AsepticSure Distribution Agreement Opens Door To Canadian Hospital Market

Hospital disinfection technology, AsepticSure, to be distributed nation-wide by Wood Wyant, Canada's largest distributor of sanitation products

New Disinfection Technology Expected To Combat Deadly CRE Threat

An innovative new vapor-mist technology, AsepticSure, appears capable of killing the much-feared CRE pathogen.

AsepticSure Disinfection System Proving Successful In Canadian Hospital Trials

A new, broad spectrum HAI reduction technology has demonstrated outstanding efficacy and efficiency in trials held at Ontario's QHC Belleville General Hospital.

Singapore Patent Opens Door To Asia For Revolutionary Hospital Disinfection Technology

AsepticSure®, an innovative new weapon in the war against hospital acquired infections receives Singaporean patent protection.

Transformix To Manufacture Medizone International's AsepticSure Technology

Innovative Canadian manufacturer, Transformix, has added Medizone International to its enviable list of clients

Tuberculosis Breakthrough - New Technology To Greatly Reduce Deadly Disease Risk In Hospitals

AsepticSure, a Highly Promising New Disinfection Technology May Hold the Key to Reducing or Even Eliminating TB from Hospitals and Tuberculosis Laboratories, Worldwide.

Medizone International Continues To Strengthen Senior Management Team

Developers of Global Infection Control Technology, AsepticSure, Secure Top-Level Management Expertise in Bid to Earn Gold Standard for Disinfection, Worldwide.

AsepticSure Patent Protection Goes Global

AsepticSure, a revolutionary decontamination technology designed to neutralize weaponized pathogens, hospital superbugs and all known food-borne bacteria, continues to expand its global patent protection program.

Canmedical Secures AsepticSure Distribution Rights For Canadian Veterinary Market

AsepticSure, a WHO award-winning vapor-mist decontamination and infection control technology is to be distributed in Canada by leading medical and veterinary products supplier, Canmedical.

AsepticSure Patent Protection Program Expanded -- Superbugs In Five Countries Get Nervous

AsepticSure, a new technology in the war against hospital acquired infections, has had its patent protection program extended to five of the world's worst-affected superbug red zones.

Canadian Patent Issued To Medizone International For AsepticSure™ Disinfection Technology

A new, peer-reviewed, vapor-based fumigant capable of significantly lowering hospital acquired infection rates worldwide, receives foundational patent protection

Medizone International Partners With NewsUSA

NewsUSA, a national social media and news feature placement company, negotiated an agreement guaranteeing Medizone International media placements equivalent to $500,000 in advertising.

Medizone International Tightens Noose On Food-Borne Pathogens, Bed Bugs And MRSA

Following a string of laboratory trial successes with its flagship product, AsepticSureâ¿¢, Medizone International has filed 3 international patent applications to protect its much-anticipated entry into the global food processing, bed bugs and sports equipment markets.

Greatest Threat To Bed Bugs Since Last Ice-Age!

International Award-Winning Vapor Mist Technology, AsepticSureâ¿¢, Poised to Eradicate Bed Bugs from Hotel and Travel Industry, Worldwide